Femoropopliteal bypass grafts--an isotope technique allowing in vivo comparison of thrombogenicity
- PMID: 6213283
- PMCID: PMC11429042
- DOI: 10.1002/bjs.1800690708
Femoropopliteal bypass grafts--an isotope technique allowing in vivo comparison of thrombogenicity
Abstract
Prosthetic femoropopliteal grafts attract platelet thrombus and often occlude in the months following implantation. Hence a technique to measure the in vivo thrombogenicity of different vascular substitutes in patients has been developed. In 28 patients the rate of accumulation of 111-indium-labelled platelets in saphenous vein, polytetrafluoroethylene (PTFE) and double velour Dacron femoropopliteal grafts was studied. One week postoperatively autologous 111In-labelled platelets were injected and the isotope emissions over the graft and contralateral leg counted. Graft thrombogenicity was calculated as the daily rise over 7 days in the ratio of counts over the graft to those over the contralateral leg. Mean thrombogenicity index (+/- s.e.mean) was greatest in the Dacron grafts at 0.24 +/- 0.03 which compared with 0.13 +/- 0.02 in PTFE (P less than 0.05). Saphenous vein was markedly less thrombogenic than either prosthetic graft with a mean index of only 0.025 +/- 0.01 (P less than 0.01). Platelet survival failed to differentiate the three graft materials, demonstrating that the direct measurement of 111In platelet deposition was a more sensitive technique.
References
-
- Grimley RP, Obeid ML, Ashton F et al. : Long term results of autologous vein bypass grafts in femoropopliteal arterial occlusion. Br. J. Surg. 1980; 66: 723–6. - PubMed
-
- Veith FJ, Moss CM, Sprayregen S et al. : Preoperative saphenous venography in arterial reconstructive surgery of the lower extremity. Surgery 1979; 85: 253–6. - PubMed
-
- Baumgartner HR: The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc. Res. 1973; 5: 167–79. - PubMed
-
- Evans G and Irvine WT: Long term arterial graft patency in relation to platelet adhesiveness, biochemical factors and anticoagulant therapy. Lancet 1966; 11: 353–5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources